TY  - JOUR
T1  - THerapy in the anemias
AU  - Kleckner MS, Jr.
Y1  - 1959/03/28
N1  - 10.1001/jama.1959.03000300106022
JO  - Journal of the American Medical Association
SP  - 1510
EP  - 1510
VL  - 169
IS  - 13
N2  - To the Editor:— 
    In the June 7, 1958, issue of The Journal, page 735, an article entitled "Current Status of Therapy in Anemias," by Lichtman, states that parenterally administered iron, for example, in the form of an iron-dextran complex (Imferon) in great excesses over a long period of time will produce "exogenous hemochromatosis." Since parenteral therapy with properly calculated dosage of iron-dextran complex should be discontinued when a hematological response has been obtained, as well as when this type of therapy fails or the patient eventually becomes anemic, iron-storage diseases, i. e., hemosiderosis or hemochromatosis, should not occur under these circumstances, because the possibility of iron overload is eliminated. The subject of iron-overload has been discussed in a textbook, "Iron in Clinical Medicine" (edited by Wallerstein and Mettier, Berkeley, University of California Press, 1958). The question of whether hemosiderosis progresses to hemochromatosis has been answered both affirmatively and negatively. Much
SN  - 0002-9955
M3  - doi: 10.1001/jama.1959.03000300106022
UR  - http://dx.doi.org/10.1001/jama.1959.03000300106022
ER  -